<DOC>
	<DOCNO>NCT02895230</DOCNO>
	<brief_summary>The research focus safety profile androgen-deprivation therapy ( ADT ) . The hypothesis safety issue , regard cardiovascular risk , homogenous across spectrum androgen-deprivation therapy modality . Our study encompass ADT modality include intermittent ADT . ADT cornerstone therapy prostate cancer management . Decisions ADT weigh improvement cancer-specific outcomes potential increase risk cardiovascular disease . The potential harm ADT precisely define accord type ADT . Those potential risk underscore importance well understand benefit ADT , especially contexts data still lacking.ADT also indicate sexually deviant behavior .</brief_summary>
	<brief_title>Androgen-Deprivation Therapy Cardiovascular Risk : A Nationwide Population-based Cohort Study</brief_title>
	<detailed_description>Our study nationwide population-based prospective cohort 4 year thanks French Health Reimbursement Agency database ( Système National d'Information Inter-Régimes de l'Assurance Maladie , SNIIRAM ) French hospital discharge database ( Programme de Médicalisation de Systèmes d'Information ; PMSI ) . A unique civil registration number assign French resident number unambiguously link two database .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Adults men , age great 18 year , Affiliation French Health System , Diagnosis prostate cancer At least one dispensation ( leading reimbursement claim ) 1.5 year period androgendeprivation therapy hospitalization orchiectomy . Orchiectomy another reason prostate cancer . Patients treat Gonadotropin Releasing Hormone agonists bilateral orchiectomy exclude analysis .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Androgen-deprivation therapy</keyword>
	<keyword>Prostate cancer</keyword>
	<keyword>Nationwide population-based cohort</keyword>
	<keyword>Myocardial infarction</keyword>
	<keyword>Ischemic stroke</keyword>
</DOC>